REMAKING MEDICINE Trademark

Trademark Overview

On Monday, April 6, 2020, a trademark application was filed for REMAKING MEDICINE with the United States Patent and Trademark Office. The USPTO has given the REMAKING MEDICINE trademark a serial number of 88860835. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 30, 2023. This trademark is owned by EQRX, Inc.. The REMAKING MEDICINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and therapeutic preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders

Research and development of pharmaceutical and therapeutic preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders
remaking medicine

General Information

Serial Number88860835
Word MarkREMAKING MEDICINE
Filing DateMonday, April 6, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and ServicesPharmaceutical and therapeutic preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders
Goods and ServicesResearch and development of pharmaceutical and therapeutic preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 13, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEQRx International, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameEQRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameEQRX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events

Event DateEvent Description
Monday, October 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 15, 2023SOU EXTENSION 5 GRANTED
Friday, March 3, 2023SOU EXTENSION 5 FILED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 27, 2022SOU EXTENSION 4 GRANTED
Tuesday, September 27, 2022SOU EXTENSION 4 FILED
Tuesday, September 27, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 28, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 23, 2022SOU EXTENSION 3 FILED
Wednesday, February 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU EXTENSION 2 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 2 FILED
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 10, 2021SOU EXTENSION 1 GRANTED
Monday, March 8, 2021SOU EXTENSION 1 FILED
Monday, March 8, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 23, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, November 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 13, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, November 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 24, 2020ASSIGNED TO EXAMINER
Monday, April 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2020NEW APPLICATION ENTERED

Related Keywords

medicine remaking inflammatory diseases disorders pharmaceutical autoimmune therapeutic oncological preparations treatment development